Celestica (CLS) Cash & Equivalents (2016 - 2026)

Celestica (CLS) has 11 years of Cash & Equivalents data on file, last reported at $378.0 million in Q1 2026.

• Cash & Equivalents for Q1 2026 came in at $378.0 million, up 24.75% year-over-year; the trailing twelve-month figure through Mar 2026 was $378.0 million (up 24.75% YoY), and the FY2025 annual result was $595.6 million, up 40.7% from the prior year.
• Cash & Equivalents slipped to $378.0 million in Q1 2026 per CLS's latest filing, from $595.6 million in the prior quarter.
• Over five years, Cash & Equivalents peaked at $595.6 million in Q4 2025 and troughed at $303.0 million in Q1 2025.
• A 5-year average of $383.1 million and a median of $372.4 million in 2022 frame the typical range for Cash & Equivalents.
• The sharpest annual moves came in 2022 and 2025: Cash & Equivalents fell 4.95% in 2022, then soared 40.7% in 2025.
• A 5-year view of Cash & Equivalents shows it stood at $374.5 million in 2022, then retreated by 1.09% to $370.4 million in 2023, then gained by 14.28% to $423.3 million in 2024, then soared by 40.7% to $595.6 million in 2025, then plunged by 36.53% to $378.0 million in 2026.
• Business Quant data shows CLS's Cash & Equivalents at $378.0 million in Q1 2026, $595.6 million in Q4 2025, and $305.9 million in Q3 2025.